FAGGIONATO, EDOARDO
 Distribuzione geografica
Continente #
EU - Europa 181
NA - Nord America 172
AS - Asia 99
SA - Sud America 2
AF - Africa 1
Totale 455
Nazione #
US - Stati Uniti d'America 171
IT - Italia 113
SG - Singapore 57
CN - Cina 32
FI - Finlandia 17
DE - Germania 12
FR - Francia 10
ES - Italia 8
NL - Olanda 6
DK - Danimarca 4
IN - India 4
RU - Federazione Russa 4
GB - Regno Unito 3
IR - Iran 3
CO - Colombia 2
HU - Ungheria 2
KR - Corea 2
SE - Svezia 2
CA - Canada 1
JP - Giappone 1
ZA - Sudafrica 1
Totale 455
Città #
Santa Clara 56
Singapore 49
Padova 21
Beijing 17
Boardman 17
Helsinki 16
Arzignano 13
Rome 11
Fairfield 10
Paese 10
Treviso 10
Belluno 6
Milan 6
Copenhagen 4
Ponzano Veneto 4
Valencia 4
Vicenza 4
Ann Arbor 3
Bagnaria Arsa 3
Chandler 3
Eindhoven 3
Los Angeles 3
Neu-Ulm 3
Redlands 3
Barcelona 2
Budapest 2
Cambridge 2
Council Bluffs 2
Des Moines 2
Falkenstein 2
Frankfurt am Main 2
Freiburg im Breisgau 2
Grenoble 2
Jamshedpur 2
Medellín 2
Medford 2
Pohang 2
Princeton 2
Roxbury 2
Trento 2
Woodbridge 2
Acton 1
Amsterdam 1
Bassano del Grappa 1
Bhubaneswar 1
Cape Town 1
Florence 1
Hamburg 1
Hisings Backa 1
Houston 1
Kilburn 1
Lappeenranta 1
Mirano 1
Mountain View 1
Munich 1
Pordenone 1
Portland 1
Prescot 1
San Diego 1
Seattle 1
Toronto 1
Uppsala 1
Venice 1
Verona 1
Totale 336
Nome #
A Comprehensive Nonlinear Mixed Effects Model of Glucose, Insulin, and C-Peptide Interaction during IVGTT 48
Modeling Between-Subject Variability in Subcutaneous Absorption of a Fast-Acting Insulin Analogue by a Nonlinear Mixed Effects Approach 46
LINKING MEAL COMPOSITION TO POSTPRANDIAL CGM TRACES IN OUTPATIENTS WITH TYPE 1 DIABETES THROUGH NON-LINEAR MIXED EFFECTS MODELING 44
Nonlinear Mixed Effects Modeling of Glucagon Kinetics in Healthy Subjects 43
The Minimally-Invasive Oral Minimal Model: Inpatient-to-outpatient Transition of the Oral Glucose Minimal Model 35
An Adaptive Model Predictive Controller to Address the Biovariability in Blood Clotting Response During Therapy With Warfarin 34
Modeling Between-Subject Variability in Subcutaneous Absorption of a Long-Acting Insulin Glargine 100 U/mL by a Nonlinear Mixed Effects Approach 34
Use of the Minimally-Invasive Oral Minimal Model to Quantify the Effect of Fat and Protein on the Postprandial Glucose Excursion in Individuals with Type 1 Diabetes under Free-living Conditions 32
REAL LIFE ESTIMATION OF POSTPRANDIAL GASTRIC RETENTION, GLUCOSE ABSORPTION AND INSULIN SENSITIVITY IN TYPE 1 DIABETES USING MINIMALLY INVASIVE TECHNOLOGIES AND COMPUTATIONAL MODELING 26
Effect of Fat Content on Postprandial Gastric Retention and Glucose Absorption in Subjects with Type 1 Diabetes during Daily Life Conditions: Assessment through a Computational Model 24
Assessing insulin sensitivity, glucose effectiveness, and β-cell responsivity using an integrated glucose, insulin, and C-peptide minimal model 23
Assessing Glucagon Kinetics through Nonlinear Mixed Effects Modeling 23
Nonlinear Mixed Effects Modeling of Glucagon Kinetics in Healthy Subjects 22
1551-P: Impaired β-Cell Responsiveness to Glucagon in Type 2 Diabetes Mellitus Assessed by a New C-Peptide Minimal Model 20
The Minimally-Invasive Oral Glucose Minimal Model: Estimation of Gastric Retention, Glucose Rate of Appearance, and Insulin Sensitivity from Type 1 Diabetes Data Collected in Real-life Conditions 19
Investigating Insulin-Lowering Mechanisms of SGLT2-Inhibition in Individuals with Post-bariatric Hypoglycaemia 19
Totale 492
Categoria #
all - tutte 2.748
article - articoli 944
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 3.692


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202110 0 0 0 0 0 0 0 0 0 0 0 10
2021/202223 0 0 0 0 0 3 7 0 0 3 3 7
2022/202346 5 0 1 0 0 1 0 0 25 9 2 3
2023/2024167 17 20 13 12 13 3 19 9 14 20 16 11
2024/2025246 39 44 25 11 89 38 0 0 0 0 0 0
Totale 492